Simply Pets Radio welcomes Dr. Joel Ehrenzweig to the show today. We are pleased that Dr. Joel took time out of his busy schedule to speak with us today. He is a man of extraordinary knowledge about the world of Veterinary medicine and shares one of the latest products on the market that he feels is a “game changer” for so many of our wonderful PetKids and animals.
Dr. Joel shares clinical trials data from his associate Dr. Terry Beardsley’s. Dr. Beardsley, is a clinical researcher behind the discovery of LTCI (Lymphocyte T-Cell Immunomodulator). LTCI is the first USDA-approved treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV). It has reportedly also shown that LTCI may show promise in treating Equine Herpes Virus (EHV), the deadly disease attacking the nation’s equine industry.
Hopefully, a further trial will prove the potential of LTCI as a major medical breakthrough in the field of immunotherapy, not only as has been shown for cats, but also to help control other inflammatory diseases in dogs, like arthritis, and EPM, endotoxemia, and laminitis in horses.”
Dr. Joel Ehrenzweig has been the Owner of multi-site practices and Chief of staff to various animal facilities during his many years in the Animal Health industry. Not only is he one of the worlds leading Veterinarians, he is also one of the top consultants regarding biotech and animal health managerial. Ehrenzweig’s extensive background makes him a highly sought after within the vast field of Veterinarian medicine. His innovative business ideas, and clinical trial developments and along with marketing strategies and product branding find him being an effective communicator to consumers, practitioners, colleagues and industry representatives all over the world.